Dealstreet

JSA advises Somerset Indus Capital Partners on Apex Hospitals exit

The transaction involved life sciences-focused private equity firm InvAscent acquiring a significant stake in Apex Hospitals via primary and secondary funding.

Bar & Bench

JSA advised Somerset Indus Capital Partners on its exit from Apex Hospitals, a leading multi-specialty hospital chain in Rajasthan.

The transaction involved life sciences-focused private equity firm InvAscent acquiring a significant stake in Apex Hospitals via primary and secondary funding.

The JSA team comprised Siddharth Mody (Lead Partner), Rohan Kumar (Partner), and Niharika Rao (Senior Associate).

InvAscent, through its India Life Sciences Fund IV, invested approximately USD 30 million (₹265 crore), enabling the acquisition of Somerset’s stake and providing fresh growth capital. Somerset achieved a complete exit from its May 2019 investment, reportedly realizing a 4x return on invested capital.

During Somerset’s holding period, Apex Hospitals is said to have tripled its revenue and recorded a four-fold increase in EBITDA. Post-transaction, Apex Hospitals’ promoters will retain majority ownership and continue to lead operations, while the new capital infusion will support expansion into western and northern India.

Vijay rally stampede: Madras High Court refuses CBI probe but urges strict conditions for political rallies

Kerala High Court mandates all courts in State to adopt AI tool to record witness depositions

CAM Partner Saurabh Sharma joins JSA in Ahmedabad

Social media intoxication leading to indiscipline among cops: MP High Court calls for remedial measures

SAM, Herbert Smith, Sullivan, Troutman Pepper Locke act on AGCO $260 million exit from TAFE

SCROLL FOR NEXT